Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-23

Clinical Trial Update: Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN [NA]

View source ↗

Summary

A proof-of-concept clinical trial is testing palonosetron and olanzapine without dexamethasone to prevent chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aloxi (palonosetron hydrochloride)
  • Zyprexa (olanzapine)

Snippet

Sponsor: Hee Jun Kim | Conditions: Chemotherapy-induced Nausea and Vomiting | NA | Status: UNKNOWN